ViCardio®, a unique blood pressure monitor developed in the UK, has beaten global competition in the prestigious IDTechEx awards, held in Berlin.
The IDTechEx Show! is hosted by IDTechEx. Since 1999 IDTechEx has provided independent market research, business intelligence and events on emerging technology to clients in over 80 countries.
Each year at the IDTechEx Show!, two companies are honoured for their achievements in developing and commercialising different aspects of wearable technology.
The judges were impressed by Tarilian Laser Technologies’ patented biosensor used in ViCardio, which is central in allowing ViCardio® to be the world’s first non-invasive, beat-to-beat, blood pressure monitor. The judges at IDTechEx, Matthew Heasley, from GSK, and Dr Akira Sakaigawa, from Huawei commented that
“ViCardio’s device has the potential to be revolutionary in blood pressure monitoring, so we are delighted to recognise this potential via this award”.
TLT & ViCardio CEO Dr Sandeep Shah said:
“We are delighted to win the Best New Wearable Technology Award, especially coming so quickly after winning awards from global accountancy firm PwC and Future Healthcare 2018. This reflects the potential of ViCardio® to transform the patient experience.”
Dr David Pearce, accepting the award in Berlin, said:
“We’re very proud to have been honoured by the largest emerging technologies conference in Europe. Wearable devices are playing an increasing role in allowing patients to take control of their own health, and ViCardio® has the potential to empower and transform the lives of those suffering from Hypertension and its related diseases.”